Protara Therapeutics (TARA) Other Operating Expenses (2019 - 2022)

Protara Therapeutics' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $29.5 million for Q4 2022.

• In Q4 2022, Other Operating Expenses changed N/A year-over-year to $29.5 million; the TTM figure through Sep 2023 stood at $29.5 million (changed N/A YoY), while the FY2022 annual figure was $29.5 million, changed N/A from the prior year.
• Other Operating Expenses was $29.5 million for Q4 2022 at Protara Therapeutics, up from -$8.8 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $29.5 million in Q4 2022 to a low of -$8.8 million in Q4 2020.
• Historically, Other Operating Expenses has averaged $3.2 million across 3 years, with a median of -$4.0 million in 2019.
• Biggest YoY gain for Other Operating Expenses was 113.38% in 2020; the steepest drop was 113.38% in 2020.
• A 3-year view of Other Operating Expenses shows it stood at -$4.1 million in 2019, then sank by 113.38% to -$8.8 million in 2020, then jumped by 435.09% to $29.5 million in 2022.
• The last three Other Operating Expenses figures came in at $29.5 million (Q4 2022), -$8.8 million (Q4 2020), and -$4.1 million (Q4 2019), per Business Quant data.